Advertisement

advertisement
OIAm2, LLC The Company

OIAm2, LLC The Company has 21 websites, 11 are singles sites and 10 are informational site to help you through your day!

Members

Gilead increases enrollment target for remdesivir trial in COVID-19 patients

advertisement
Home Blogs > Business
Apr 17 '20 | By oiam2companyadmin | Views: 38 | Comments: 0

?m=02&d=20200417&t=2&i=1515493600&w=1200

Gilead Sciences Inc on Friday increased enrollment target by 3,600 for a trial testing its experimental drug, remdesivir, in severe COVID-19 patients, a day after a media report said the drug was showing promise.
businessNews?d=yIl2AUoC8zA businessNews?i=i4iFeKK0zWQ:wCDo6qZ9B0s:F businessNews?i=i4iFeKK0zWQ:wCDo6qZ9B0s:V

Source: https://www.reuters.com/article/us-gilead-sciences-stocks/gilead-increases-enrollment-target-for-remdesivir-trial-in-covid-19-patients-idUSKBN21Z25V?feedType=RSS&feedName=businessNews

Share:
No comments
You need to sign in to comment
advertisement

Advertisement

advertisement
Google this
Tineye this
Bing this
Yandex this